Published in Virology on April 14, 1997
Dengue and dengue hemorrhagic fever. Clin Microbiol Rev (1998) 19.59
Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis (2003) 4.29
Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26
The epidemiology of dengue in the americas over the last three decades: a worrisome reality. Am J Trop Med Hyg (2010) 4.09
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev (2009) 3.61
Microevolution and virulence of dengue viruses. Adv Virus Res (2003) 3.41
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol (2000) 3.21
Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol (2009) 3.19
Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis (2012) 3.06
Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J Clin Microbiol (1999) 2.96
Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol (2005) 2.82
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol (2005) 2.50
Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol (2000) 2.49
Invasion and maintenance of dengue virus type 2 and type 4 in the Americas. J Virol (2005) 2.44
Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol (2005) 2.37
Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med (2011) 2.29
Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis (2001) 2.20
Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia. PLoS Negl Trop Dis (2010) 2.17
Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti. Am J Trop Med Hyg (2003) 2.16
Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol (2014) 2.16
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity. Science (2017) 2.10
Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus. Am J Trop Med Hyg (2006) 2.07
American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog (2010) 2.03
Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A (2005) 2.02
Development and evaluation of fluorogenic TaqMan reverse transcriptase PCR assays for detection of dengue virus types 1 to 4. J Clin Microbiol (2004) 2.01
Dengue incidence in urban and rural Cambodia: results from population-based active fever surveillance, 2006-2008. PLoS Negl Trop Dis (2010) 1.98
Larval competition alters susceptibility of adult Aedes mosquitoes to dengue infection. Proc Biol Sci (2008) 1.98
Endemic dengue associated with the co-circulation of multiple viral lineages and localized density-dependent transmission. PLoS Pathog (2011) 1.87
The history of dengue outbreaks in the Americas. Am J Trop Med Hyg (2012) 1.87
Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma. J Virol Methods (2011) 1.85
Dengue virus evolution and virulence models. Clin Infect Dis (2007) 1.64
Convergent antibody signatures in human dengue. Cell Host Microbe (2013) 1.64
Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol (2009) 1.57
Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells. PLoS Pathog (2009) 1.56
Dengue--quo tu et quo vadis? Viruses (2011) 1.50
Dengue-1 virus clade replacement in Thailand associated with enhanced mosquito transmission. J Virol (2011) 1.42
Reemergence of dengue virus type-3 (subtype-III) in India: implications for increased incidence of DHF & DSS. Virol J (2006) 1.41
Dengue viruses - an overview. Infect Ecol Epidemiol (2013) 1.40
Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis (1998) 1.38
Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2. BMC Infect Dis (2004) 1.35
2nd International external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl Trop Dis (2010) 1.34
Dengue 1 diversity and microevolution, French Polynesia 2001-2006: connection with epidemiology and clinics. PLoS Negl Trop Dis (2009) 1.32
Climatic factors influencing dengue cases in Dhaka city: a model for dengue prediction. Indian J Med Res (2012) 1.29
Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam. PLoS Negl Trop Dis (2011) 1.29
Endurance, refuge, and reemergence of dengue virus type 2, Puerto Rico, 1986-2007. Emerg Infect Dis (2011) 1.28
RNA virus genomics: a world of possibilities. J Clin Invest (2009) 1.23
Host genetic risk factors for West Nile virus infection and disease progression. PLoS One (2011) 1.22
Asymmetric competitive suppression between strains of dengue virus. BMC Microbiol (2008) 1.21
Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]. PLoS Pathog (2013) 1.20
Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient. J Gen Virol (2007) 1.16
Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem (2011) 1.16
Dengue virus virulence and transmission determinants. Curr Top Microbiol Immunol (2010) 1.15
Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization. PLoS Negl Trop Dis (2012) 1.14
Circulation of different lineages of dengue virus type 2 in Central America, their evolutionary time-scale and selection pressure analysis. PLoS One (2011) 1.13
Detection and serotyping of dengue virus in serum samples by multiplex reverse transcriptase PCR-ligase detection reaction assay. J Clin Microbiol (2008) 1.13
Viral and epidemiological determinants of the invasion dynamics of novel dengue genotypes. PLoS Negl Trop Dis (2010) 1.12
Dengue viruses cluster antigenically but not as discrete serotypes. Science (2015) 1.12
Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J Virol (2005) 1.11
Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiol (2011) 1.11
Recent emergence of dengue virus serotype 4 in French Polynesia results from multiple introductions from other South Pacific Islands. PLoS One (2011) 1.10
Genetic characterization of newly reintroduced dengue virus type 3 in Martinique (French West Indies). J Clin Microbiol (2003) 1.08
IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner. PLoS Negl Trop Dis (2011) 1.06
Characterization of Dengue virus type 2: new insights on the 2010 Brazilian epidemic. PLoS One (2010) 1.06
Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens. Clin Vaccine Immunol (2007) 1.04
Phylogenetic history demonstrates two different lineages of dengue type 1 virus in Colombia. Virol J (2010) 1.03
Displacement of the predominant dengue virus from type 2 to type 1 with a subsequent genotype shift from IV to I in Surabaya, Indonesia 2008-2010. PLoS One (2011) 1.03
Understanding the dengue viruses and progress towards their control. Biomed Res Int (2013) 1.02
Simultaneous circulation of genotypes I and III of dengue virus 3 in Colombia. Virol J (2008) 1.02
Molecular detection and typing of dengue viruses from archived tissues of fatal cases by rt-PCR and sequencing: diagnostic and epidemiologic implications. Am J Trop Med Hyg (2012) 1.02
The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes. Am Nat (2009) 1.01
Association of human immune response to Aedes aegypti salivary proteins with dengue disease severity. Parasite Immunol (2012) 0.99
Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, singapore. Am J Trop Med Hyg (2015) 0.98
Circulation of different lineages of Dengue virus 2, genotype American/Asian in Brazil: dynamics and molecular and phylogenetic characterization. PLoS One (2013) 0.97
Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2. Clin Vaccine Immunol (2007) 0.97
Host genetic susceptibility to severe dengue infection. Trop Med Health (2011) 0.94
Phylogenetic studies reveal existence of multiple lineages of a single genotype of DENV-1 (genotype III) in India during 1956-2007. Virol J (2009) 0.94
Clinical and virological descriptive study in the 2011 outbreak of dengue in the Amazonas, Brazil. PLoS One (2014) 0.94
Return of epidemic dengue in the United States: implications for the public health practitioner. Public Health Rep (2012) 0.92
Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans. PLoS Negl Trop Dis (2012) 0.90
Simple Prognostic Criteria can Definitively Identify Patients who Develop Severe Versus Non-Severe Dengue Disease, or Have Other Febrile Illnesses. J Clin Med Res (2012) 0.89
Detection of dengue virus NS1 antigen in infected Aedes aegypti using a commercially available kit. Am J Trop Med Hyg (2012) 0.88
An outbreak of dengue fever in St. Croix (US Virgin Islands), 2005. PLoS One (2010) 0.88
Lineage II of Southeast Asian/American DENV-2 is associated with a severe dengue outbreak in the Peruvian Amazon. Am J Trop Med Hyg (2014) 0.88
Phylogenetic reconstruction of dengue virus type 2 in Colombia. Virol J (2012) 0.87
Antibody responses to Asian and American genotypes of dengue 2 virus in immunized mice. Clin Diagn Lab Immunol (2005) 0.87
Twenty years of DENV-2 activity in Brazil: molecular characterization and phylogeny of strains isolated from 1990 to 2010. PLoS Negl Trop Dis (2013) 0.87
Evasion of the human innate immune system by dengue virus. Immunol Res (2012) 0.87
Dengue seroprevalence and risk factors for past and recent viral transmission in Venezuela: a comprehensive community-based study. Am J Trop Med Hyg (2014) 0.86
Complete genome sequencing and phylogenetic analysis of dengue type 1 virus isolated from Jeddah, Saudi Arabia. Virol J (2015) 0.86
Prolonged co-circulation of two distinct Dengue virus Type 3 lineages in the hyperendemic area of Medellin, Colombia. Am J Trop Med Hyg (2010) 0.86
Emergence of a new lineage of dengue virus type 2 identified in travelers entering Western Australia from Indonesia, 2010-2012. PLoS Negl Trop Dis (2015) 0.85
Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes. Virology (2011) 0.85
Lineage shift in Indian strains of Dengue virus serotype-3 (Genotype III), evidenced by detection of lineage IV strains in clinical cases from Kerala. Virol J (2013) 0.85
Homology of complete genome sequences for dengue virus type-1, from dengue-fever- and dengue-haemorrhagic-fever-associated epidemics in Hawaii and French Polynesia. Ann Trop Med Parasitol (2010) 0.84
Exploratory space-time analysis of dengue incidence in Trinidad: a retrospective study using travel hubs as dispersal points, 1998-2004. Parasit Vectors (2014) 0.84
Dengue in travelers: kinetics of viremia and NS1 antigenemia and their associations with clinical parameters. PLoS One (2013) 0.84
The Complete Genome Phylogeny of Geographically Distinct Dengue Virus Serotype 2 Isolates (1944-2013) Supports Further Groupings within the Cosmopolitan Genotype. PLoS One (2015) 0.84
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg (1989) 10.52
A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg (1988) 8.54
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
Neurological manifestations of dengue infection. Lancet (2000) 5.69
Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg (1987) 5.53
Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis (1997) 5.13
Early clinical and laboratory indicators of acute dengue illness. J Infect Dis (1997) 5.00
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg (1988) 4.65
Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26
Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78
Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol (1982) 3.44
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol (2001) 3.11
Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg (1999) 3.11
Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis (1999) 2.96
Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis. J Clin Virol (1999) 2.74
Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet (1996) 2.72
Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis (1985) 2.59
Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology (2002) 2.53
Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J Clin Microbiol (1998) 2.50
Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45
Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet (1998) 2.41
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
Task-dependent changes in the size of response to magnetic brain stimulation in human first dorsal interosseous muscle. J Physiol (1989) 2.30
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens (2002) 2.18
Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol (1982) 2.10
Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay. Clin Diagn Lab Immunol (2001) 2.09
Dengue chikungunya virus infection in man in Thailand, 1962-1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Am J Trop Med Hyg (1969) 2.07
Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol (2002) 2.04
Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med (1988) 2.03
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Spatial organization of large-scale chromatin domains in the nucleus: a magnified view of single chromosome territories. J Cell Biol (1997) 1.94
Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America. Proc Natl Acad Sci U S A (1995) 1.83
Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis (1999) 1.82
Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol (1998) 1.81
Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80
Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol (1999) 1.79
Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus. Clin Diagn Lab Immunol (1997) 1.78
Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers. Am J Trop Med Hyg (1997) 1.75
Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis (1997) 1.75
Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol (1985) 1.73
Suppressor cells present in the spleens of Trypanosoma cruzi-infected mice. J Immunol (1979) 1.70
Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat (1997) 1.69
An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg (1968) 1.68
Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg (2001) 1.65
Patterns of central motor reorganization in hemiplegic cerebral palsy. Brain (1993) 1.64
Task-dependent changes in cutaneous reflexes recorded from various muscles controlling finger movement in man. J Physiol (1989) 1.63
Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg (1998) 1.63
Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl (1994) 1.61
A neurophysiological study of mirror movements in adults and children. Ann Neurol (1999) 1.60
Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J Med Virol (1995) 1.58
High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg (1993) 1.56
Multicentre evaluation of dengue IgM dot enzyme immunoassay. Clin Diagn Virol (1996) 1.49
IgM capture ELISA for detection of IgM antibodies to dengue virus: comparison of 2 formats using hemagglutinins and cell culture derived antigens. Southeast Asian J Trop Med Public Health (1992) 1.49
Isolation, characterization and geographic distribution of Caño Delgadito virus, a newly discovered South American hantavirus (family Bunyaviridae). Virus Res (1997) 1.48
Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease. Yale J Biol Med (1970) 1.48
Transmission of HIV in dialysis centre. Lancet (1995) 1.47
An outbreak of dengue virus at Rio de Janeiro--1986. Mem Inst Oswaldo Cruz (1987) 1.46
Analysis of activity of muscle spindles of the jaw-closing muscles during normal movements in the cat. J Physiol (1975) 1.46
Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses. Yale J Biol Med (1970) 1.45
The behavior of bacteria designed for biodegradation. Biotechnology (N Y) (1994) 1.44
Retrospective study on dengue fatal cases. Clin Neuropathol (1997) 1.43
[HIV infection and chronic brucellosis]. Enferm Infecc Microbiol Clin (1992) 1.42
Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis (1980) 1.42
Antigen 43 facilitates formation of multispecies biofilms. Environ Microbiol (2000) 1.41
[The influence of a prior appointment on primary care consultations in the Murcia region]. Aten Primaria (1992) 1.40
Natural rodent host associations of Guanarito and pirital viruses (Family Arenaviridae) in central Venezuela. Am J Trop Med Hyg (1999) 1.39
[Respiratory cryptosporidiosis as first manifestation of AIDS]. Enferm Infecc Microbiol Clin (1996) 1.39
Evidence for bilateral innervation of certain homologous motoneurone pools in man. J Physiol (1994) 1.39
Xanthogranulomatous ureteritis. J Urol (1975) 1.38
Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay. J Clin Microbiol (1998) 1.37
Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor. J Virol (1999) 1.36
Mirror movements in X-linked Kallmann's syndrome. I. A neurophysiological study. Brain (1997) 1.35
Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology (2001) 1.33
Plasticity of central motor pathways in children with hemiplegic cerebral palsy. Neurology (1991) 1.33
Fatal outcome in Japanese encephalitis. Am J Trop Med Hyg (1985) 1.30
Cholesterol orientation and dynamics in dimyristoylphosphatidylcholine bilayers: a solid state deuterium NMR analysis. Biophys J (1999) 1.30
Dengue-2 vaccine: viremia and immune responses in rhesus monkeys. Infect Immun (1980) 1.27
DNA transfer from Agrobacterium to Zea mays or Brassica by agroinfection is dependent on bacterial virulence functions. Mol Gen Genet (1989) 1.25
Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol (2001) 1.24
Comparison of PanBio dengue duo enzyme-linked immunosorbent assay (ELISA) and MRL dengue fever virus immunoglobulin M capture ELISA for diagnosis of dengue virus infections in Southeast Asia. Clin Diagn Lab Immunol (1999) 1.21
T-DNA transfer to maize cells: histochemical investigation of beta-glucuronidase activity in maize tissues. Proc Natl Acad Sci U S A (1993) 1.21
Direct detection of wild poliovirus circulation by stool surveys of healthy children and analysis of community wastewater. J Infect Dis (1993) 1.19
Distribution and etiology of leishmaniasis in Colombia. Am J Trop Med Hyg (1990) 1.19
Dengue infection with central nervous system manifestations. Southeast Asian J Trop Med Public Health (1999) 1.19
Proline catabolism by Pseudomonas putida: cloning, characterization, and expression of the put genes in the presence of root exudates. J Bacteriol (2000) 1.19
Immunoglobulin response and viremia in dengue-vaccinated gibbons repeatedly challenged with Japanese encephalitis virus. Am J Epidemiol (1973) 1.18
Construction and behavior of biologically contained bacteria for environmental applications in bioremediation. Appl Environ Microbiol (1995) 1.18
Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax (1986) 1.17
The dynamics of coiled bodies in the nucleus of adenovirus-infected cells. Mol Biol Cell (1996) 1.16
Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am J Physiol (1999) 1.16
Human immune responses to dengue viruses. Southeast Asian J Trop Med Public Health (1990) 1.15